Search research articles
Contact Us
Filters
Showing results (51-60 of 123) with videos related to
Page
of 13
Sort By:
Mbio
|
October 11, 2018
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E Gralinski, Timothy P Sheahan, Thomas E Morrison, et al.
Bioorganic & Medicinal Chemistry
|
June 8, 2025
Exploration of 4'-fluoro fleximer nucleoside analogues as potential broad-spectrum antiviral agents
Kyle A Davis, Jason K Smith, Jessica L Smith, et al.
The Journal of Infectious Diseases
|
May 7, 2021
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Shuntai Zhou, Collin S Hill, Sanjay Sarkar, et al.
Research Square
|
June 2, 2021
Fc-engineered antibody therapeutics with improved efficacy against COVID-19
Rachel Yamin, Andrew T Jones, Hans-Heinrich Hoffmann, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Advancement in Cellular Topographic and Nanoparticle Capture Imaging by High Resolution Microscopy Incorporating a Freeze-Drying and Gaseous Nitrogen-based Approach
Kunihiro Uryu, Nadine Soplop, Timothy P Sheahan, et al.
European Heart Journal
|
June 9, 2020
COVID-19: from epidemiology to treatment
J M Pericàs, M Hernandez-Meneses, T P Sheahan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 3, 2023
Replacing Plain Radiograph with ultra-low dose CT thorax in cystic fibrosis (CF) in the era of CFTR modulation and its impact on cumulative effective dose
Kevin P Sheahan, Alexander T O'Mahony, David Morrissy, et al.
Antiviral Research
|
June 25, 2019
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Ariane J Brown, John J Won, Rachel L Graham, et al.
Virus Research
|
January 15, 2024
Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection
John M Powers, Sarah R Leist, Michael L Mallory, et al.
Nature
|
September 21, 2021
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Rachel Yamin, Andrew T Jones, Hans-Heinrich Hoffmann, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 123) with videos related to
Sort By:
Page
of 13
Mbio
|
October 11, 2018
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E Gralinski, Timothy P Sheahan, Thomas E Morrison, et al.
Bioorganic & Medicinal Chemistry
|
June 8, 2025
Exploration of 4'-fluoro fleximer nucleoside analogues as potential broad-spectrum antiviral agents
Kyle A Davis, Jason K Smith, Jessica L Smith, et al.
The Journal of Infectious Diseases
|
May 7, 2021
β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
Shuntai Zhou, Collin S Hill, Sanjay Sarkar, et al.
Research Square
|
June 2, 2021
Fc-engineered antibody therapeutics with improved efficacy against COVID-19
Rachel Yamin, Andrew T Jones, Hans-Heinrich Hoffmann, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Advancement in Cellular Topographic and Nanoparticle Capture Imaging by High Resolution Microscopy Incorporating a Freeze-Drying and Gaseous Nitrogen-based Approach
Kunihiro Uryu, Nadine Soplop, Timothy P Sheahan, et al.
European Heart Journal
|
June 9, 2020
COVID-19: from epidemiology to treatment
J M Pericàs, M Hernandez-Meneses, T P Sheahan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 3, 2023
Replacing Plain Radiograph with ultra-low dose CT thorax in cystic fibrosis (CF) in the era of CFTR modulation and its impact on cumulative effective dose
Kevin P Sheahan, Alexander T O'Mahony, David Morrissy, et al.
Antiviral Research
|
June 25, 2019
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Ariane J Brown, John J Won, Rachel L Graham, et al.
Virus Research
|
January 15, 2024
Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection
John M Powers, Sarah R Leist, Michael L Mallory, et al.
Nature
|
September 21, 2021
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Rachel Yamin, Andrew T Jones, Hans-Heinrich Hoffmann, et al.
Page
of 13